Q3 2020 Sales Performance

GSK Vaccines is well positioned in US, EU and ROW 2019 Vaccines sales for top four companies Pfizer Merck US £12,867m +10.2% CER GSK £3,905m 30.3% Pfizer EU Merck £3,018m +3.7% CER Sanofi Sanofi GSK £1,488m 49.3% Pfizer Merck ROW £7,918m +26.6% CER GSK £1,764m 22.3% Sanofi 54% of global vaccines market 13% of global vaccines market 33% of global vaccines market gsk GSK has highest global market share by value of the big 4 vaccines companies with 30.1% Data from company filings. Merck does not report on EU region - all sales included in ROW 66

View entire presentation